Iris Grossman

Iris Grossman

Company: Eleven Therapeutics

Job title: Chief Strategy Officer


RNAi 2.0: Massively Parallel Functional Platforms De-Risk & Accelerate R&D 3:30 pm

Quantitative functional screens identify single-digit pico-molar hits and optimize PK properties Fit-for-purpose synthetic biology systems validate leads and teach the rational design prediction engine Extra-hepatic targeting, using prophylactic and/or treatment regimens are becoming a realityRead more

day: Day Two

Panel Discussion – Delivery Carriers for Efficient siRNA Therapies 9:45 am

With the development of new carrier technologies for delivery of siRNA therapeutics, there is a greater need to understand better formulation and mechanistic strategies to enhance efficacy and reduce toxicity. From design to development, we will delve deeper into techniques beyond GalNac for effective siRNA therapeutic delivery How to design novel carriers to reduce toxicity…Read more

day: Day One

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.